Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Indena is a leading Italian company specializing in the identification, development, and production of active principles derived from plants for use in the pharmaceutical, health food, and personal care industries. The company is widely recognized for its proprietary standardized extract, Polinacea, which is derived from Echinacea angustifolia and utilized as an immune-modulating agent and vaccine adjuvant. Indena operates as a high-tech CDMO, leveraging over a century of experience in phytochemistry to provide customized formulation and manufacturing services. Their business model integrates advanced research and development with large-scale industrial production, focusing on high-quality botanical ingredients supported by clinical validation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Polinacea.